Trial intelligence / Profile preview

Phase II trial of antigen-pulsed dendritic cells plus modified FOLFOX in metastatic colorectal cancer

ChiCTR-TRC-08000146Phase 2Completed

Sponsor
Naval Medical University
Start
Jan 2005
Countries
1
01

Overview

Phase 2, open-label trial of APDC in colorectal cancer (CRC) (2 arms), sponsored by Naval Medical University. Primary endpoint: Objective response rate. Started Jan 2005; status: completed.

02

Drugs

APDC
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on ChiCTR-TRC-08000146.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-08000146.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call